Clinical effect of ganlixin in treating hepatitis patients with viral infectious diseases
Objective To explore the value of ganlixin in the treatment of patients with hepatitis viral infectious diseases. Methods 100 cases of hepatitis viral infectious disease patients were selected as the research objects from February 2015 to February 2016, according to the differences of treatment, patients were divided into the experiment group and the control group, the control group was treated with routine treatment, the experimental group was treated with glycyrrhizic acid, the results of the treatment of patients with hepatitis viral infections in two groups were compared. Results The total effective rate in the experimental group (94.00%) was significantly better than that (74.00%) in the control group (P<0.05). There was no statistical significance in adverse reactions between 2 groups. The hepatic functional index of the experimental group was better than that of the control group (P<0.05). Conclusion The treatment of hepatitis patients with viral infectious diseases could improve the curative effect of treatment and liver function index with high safety and significance.
ganlixinviral infectious diseases of hepatitistherapeutic value
NETL
NSTL
万方数据
维普
